TSPO and central nervous system cancer: Despite being less tumor-specific, PET imaging using radioligands targeting the translocator protein (TSPO), which is upregulated not only in tumor cells but also in activated microglia or macrophages, has demonstrated correlations with histologic tumor grade, specific transcriptional glioma subtypes, and survival [22–27].